Trending stock analysis: Why Moderna Stock Soared Last Week
Trending stock analysis: Moderna stock soared last week followed the revelation of insider buying activity and a favorable ruling in a patent dispute against Pfizer (PFE) and BioNTech (BNTX).
Insider Purchases Worth Millions
In recent filings with the Securities and Exchange Commission (SEC), it was revealed that two members of Moderna’s board made significant purchases of the company’s stock. CEO Stéphane Bancel and board member Paul Sagan bought a substantial amount of common stock.
Bancel acquired a large number of shares through Boston Biotech Ventures, a firm he controls. On the same day, Sagan also purchased a notable quantity of shares. This insider activity typically indicates strong confidence in the company’s future prospects,…
